Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library

Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library

BackgroundColchicine is a traditional medication that is currently approved to treat gout and familial Mediterranean fever (FMF). However, colchicine has a wide range of anti-inflammatory activities, and several studies have indicated that it may be useful in a variety of other conditions, such as r...

Full description

Bibliographic Details
Main Authors: Jisun Oh, Hyun−Ju An, Hyun Jeong Yeo, Sujin Choi, Jisu Oh, Segi Kim, Jin Man Kim, Junwon Choi, Soonchul Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Saos-2
U2OS
drug repositioning
FDA-approved drugs
colchicine
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.893951/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.893951/full

Similar Items